Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1997 Aug;71(8):6208–6213. doi: 10.1128/jvi.71.8.6208-6213.1997

Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides.

R Zhang 1, J Durkin 1, W T Windsor 1, C McNemar 1, L Ramanathan 1, H V Le 1
PMCID: PMC191885  PMID: 9223519

Abstract

We probed the substrate specificity of a recombinant noncovalent complex of the full-length hepatitis C virus (HCV) NS3 serine protease and NS4A cofactor, using a series of small synthetic peptides derived from the three trans-cleavage sites of the HCV nonstructural protein sequence. We observed a distinct cleavage site preference exhibited by the enzyme complex. The values of the turnover number (k(cat)) for the most efficient NS4A/4B, 4B/5A, and 5A/5B peptide substrates were 1.6, 11, and 8 min(-1), respectively, and the values for the corresponding Michaelis-Menten constants (Km) were 280, 160, and 16 microM, providing catalytic efficiency values (k(cat)/Km) of 92, 1,130, and 8,300 M(-1) s(-1). An alanine-scanning study for an NS5A/5B substrate (P6P4') revealed that P1 Cys and P3 Val were critical. Finally, substitutions at the scissile P1 Cys residue by homocysteine (Hcy), S-methylcysteine (Mcy), Ala, S-ethylcysteine (Ecy), Thr, Met, D-Cys, Ser, and penicillamine (Pen) produced progressively less efficient substrates, revealing a stringent stereochemical requirement for a Cys residue at this position.

Full Text

The Full Text of this article is available as a PDF (154.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
  2. Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen H. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol. 1994 Aug;68(8):5045–5055. doi: 10.1128/jvi.68.8.5045-5055.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen H. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol. 1993 Jul;67(7):3835–3844. doi: 10.1128/jvi.67.7.3835-3844.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartenschlager R., Ahlborn-Laake L., Yasargil K., Mous J., Jacobsen H. Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. J Virol. 1995 Jan;69(1):198–205. doi: 10.1128/jvi.69.1.198-205.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bartenschlager R., Lohmann V., Wilkinson T., Koch J. O. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol. 1995 Dec;69(12):7519–7528. doi: 10.1128/jvi.69.12.7519-7528.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bianchi E., Steinkühler C., Taliani M., Urbani A., De Francesco R., Pessi A. Synthetic depsipeptide substrates for the assay of human hepatitis C virus protease. Anal Biochem. 1996 Jun 1;237(2):239–244. doi: 10.1006/abio.1996.0235. [DOI] [PubMed] [Google Scholar]
  7. Bukh J., Miller R. H., Kew M. C., Purcell R. H. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1848–1851. doi: 10.1073/pnas.90.5.1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chambers T. J., Weir R. C., Grakoui A., McCourt D. W., Bazan J. F., Fletterick R. J., Rice C. M. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8898–8902. doi: 10.1073/pnas.87.22.8898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chen P., Tsuge H., Almassy R. J., Gribskov C. L., Katoh S., Vanderpool D. L., Margosiak S. A., Pinko C., Matthews D. A., Kan C. C. Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad. Cell. 1996 Sep 6;86(5):835–843. doi: 10.1016/s0092-8674(00)80157-9. [DOI] [PubMed] [Google Scholar]
  10. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  11. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2451–2455. doi: 10.1073/pnas.88.6.2451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Darke P. L., Chen E., Hall D. L., Sardana M. K., Veloski C. A., LaFemina R. L., Shafer J. A., Kuo L. C. Purification of active herpes simplex virus-1 protease expressed in Escherichia coli. J Biol Chem. 1994 Jul 22;269(29):18708–18711. [PubMed] [Google Scholar]
  13. DiIanni C. L., Mapelli C., Drier D. A., Tsao J., Natarajan S., Riexinger D., Festin S. M., Bolgar M., Yamanaka G., Weinheimer S. P. In vitro activity of the herpes simplex virus type 1 protease with peptide substrates. J Biol Chem. 1993 Dec 5;268(34):25449–25454. [PubMed] [Google Scholar]
  14. Failla C., Tomei L., De Francesco R. An amino-terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J Virol. 1995 Mar;69(3):1769–1777. doi: 10.1128/jvi.69.3.1769-1777.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Failla C., Tomei L., De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol. 1994 Jun;68(6):3753–3760. doi: 10.1128/jvi.68.6.3753-3760.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Failla CM, Pizzi E, Francesco RD, Tramontano A. Redesigning the substrate specificity of the hepatitis C virus NS3 protease. Fold Des. 1995;1(1):35–42. [PubMed] [Google Scholar]
  17. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10583–10587. doi: 10.1073/pnas.90.22.10583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol. 1993 May;67(5):2832–2843. doi: 10.1128/jvi.67.5.2832-2843.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993 Mar;67(3):1385–1395. doi: 10.1128/jvi.67.3.1385-1395.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Grøn H., Meldal M., Breddam K. Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramolecular quenching. Biochemistry. 1992 Jul 7;31(26):6011–6018. doi: 10.1021/bi00141a008. [DOI] [PubMed] [Google Scholar]
  21. Hahm B., Han D. S., Back S. H., Song O. K., Cho M. J., Kim C. J., Shimotohno K., Jang S. K. NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J Virol. 1995 Apr;69(4):2534–2539. doi: 10.1128/jvi.69.4.2534-2539.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hall D. L., Darke P. L. Activation of the herpes simplex virus type 1 protease. J Biol Chem. 1995 Sep 29;270(39):22697–22700. doi: 10.1074/jbc.270.39.22697. [DOI] [PubMed] [Google Scholar]
  23. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5547–5551. doi: 10.1073/pnas.88.13.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993 Aug;67(8):4665–4675. doi: 10.1128/jvi.67.8.4665-4675.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kaito M., Watanabe S., Tsukiyama-Kohara K., Yamaguchi K., Kobayashi Y., Konishi M., Yokoi M., Ishida S., Suzuki S., Kohara M. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol. 1994 Jul;75(Pt 7):1755–1760. doi: 10.1099/0022-1317-75-7-1755. [DOI] [PubMed] [Google Scholar]
  26. Kakiuchi N., Hijikata M., Komoda Y., Tanji Y., Hirowatari Y., Shimotohno K. Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate. Biochem Biophys Res Commun. 1995 May 25;210(3):1059–1065. doi: 10.1006/bbrc.1995.1764. [DOI] [PubMed] [Google Scholar]
  27. Kim J. L., Morgenstern K. A., Lin C., Fox T., Dwyer M. D., Landro J. A., Chambers S. P., Markland W., Lepre C. A., O'Malley E. T. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell. 1996 Oct 18;87(2):343–355. doi: 10.1016/s0092-8674(00)81351-3. [DOI] [PubMed] [Google Scholar]
  28. Kolykhalov A. A., Agapov E. V., Rice C. M. Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing. J Virol. 1994 Nov;68(11):7525–7533. doi: 10.1128/jvi.68.11.7525-7533.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  30. Lin C., Lindenbach B. D., Prágai B. M., McCourt D. W., Rice C. M. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol. 1994 Aug;68(8):5063–5073. doi: 10.1128/jvi.68.8.5063-5073.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lin C., Prágai B. M., Grakoui A., Xu J., Rice C. M. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. J Virol. 1994 Dec;68(12):8147–8157. doi: 10.1128/jvi.68.12.8147-8157.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lin C., Rice C. M. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7622–7626. doi: 10.1073/pnas.92.17.7622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Love R. A., Parge H. E., Wickersham J. A., Hostomsky Z., Habuka N., Moomaw E. W., Adachi T., Hostomska Z. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell. 1996 Oct 18;87(2):331–342. doi: 10.1016/s0092-8674(00)81350-1. [DOI] [PubMed] [Google Scholar]
  34. Mori A., Yamada K., Kimura J., Koide T., Yuasa S., Yamada E., Miyamura T. Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli. FEBS Lett. 1996 Jan 2;378(1):37–42. doi: 10.1016/0014-5793(95)01423-3. [DOI] [PubMed] [Google Scholar]
  35. Purcell R. H. Hepatitis C virus: historical perspective and current concepts. FEMS Microbiol Rev. 1994 Jul;14(3):181–191. doi: 10.1111/j.1574-6976.1994.tb00087.x. [DOI] [PubMed] [Google Scholar]
  36. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Ohta Y. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6547–6549. doi: 10.1073/pnas.87.17.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sardana V. V., Wolfgang J. A., Veloski C. A., Long W. J., LeGrow K., Wolanski B., Emini E. A., LaFemina R. L. Peptide substrate cleavage specificity of the human cytomegalovirus protease. J Biol Chem. 1994 May 20;269(20):14337–14340. [PubMed] [Google Scholar]
  38. Satoh S., Tanji Y., Hijikata M., Kimura K., Shimotohno K. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J Virol. 1995 Jul;69(7):4255–4260. doi: 10.1128/jvi.69.7.4255-4260.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Shimizu Y., Yamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satoh S., Shimotohno K. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J Virol. 1996 Jan;70(1):127–132. doi: 10.1128/jvi.70.1.127-132.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Steinkühler C., Tomei L., De Francesco R. In vitro activity of hepatitis C virus protease NS3 purified from recombinant Baculovirus-infected Sf9 cells. J Biol Chem. 1996 Mar 15;271(11):6367–6373. doi: 10.1074/jbc.271.11.6367. [DOI] [PubMed] [Google Scholar]
  41. Steinkühler C., Urbani A., Tomei L., Biasiol G., Sardana M., Bianchi E., Pessi A., De Francesco R. Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol. 1996 Oct;70(10):6694–6700. doi: 10.1128/jvi.70.10.6694-6700.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stubbs M. T., Oschkinat H., Mayr I., Huber R., Angliker H., Stone S. R., Bode W. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem. 1992 May 15;206(1):187–195. doi: 10.1111/j.1432-1033.1992.tb16916.x. [DOI] [PubMed] [Google Scholar]
  43. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991 Mar;65(3):1105–1113. doi: 10.1128/jvi.65.3.1105-1113.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Taliani M., Bianchi E., Narjes F., Fossatelli M., Urbani A., Steinkühler C., De Francesco R., Pessi A. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem. 1996 Aug 15;240(1):60–67. doi: 10.1006/abio.1996.0331. [DOI] [PubMed] [Google Scholar]
  45. Tanji Y., Hijikata M., Satoh S., Kaneko T., Shimotohno K. Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J Virol. 1995 Mar;69(3):1575–1581. doi: 10.1128/jvi.69.3.1575-1581.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 1993 Jul;67(7):4017–4026. doi: 10.1128/jvi.67.7.4017-4026.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Urbani A., Bianchi E., Narjes F., Tramontano A., De Francesco R., Steinkühler C., Pessi A. Substrate specificity of the hepatitis C virus serine protease NS3. J Biol Chem. 1997 Apr 4;272(14):9204–9209. doi: 10.1074/jbc.272.14.9204. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES